Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia
Not available.
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Ferrata Storti Foundation
2025-07-01
|
| Reeks: | Haematologica |
| Online toegang: | https://haematologica.org/article/view/12177 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
